[1]
“Perbedaan β-crosslaps Serum Penderita Karsinoma Payudara Pascamenopause antara yang Diberikan Anastrozol dan Tamoksifen”, MKB, vol. 47, no. 4, pp. 207–211, Dec. 2015, Accessed: Jul. 07, 2026. Available: https://beta.unpadmedjournals.id/index.php/mkb/article/view/615